BCRX ▲ +1.0% - BioCryst Pharmaceuticals, Inc.
$BCRX - BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
21-OCT-2026 07:00 AM ET
Share this post
More filings for $BCRX
BCRX ▼ -0.2% - BioCryst Pharmaceuticals, Inc.Oct 5, 2026BCRX ▼ -0.7% - BioCryst Pharmaceuticals, Inc.Sep 1, 2026BCRX - BioCryst Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026
View full $BCRX filing history →💬 Comments
Loading comments…
Leave a comment